Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials

Eur Respir J. 2018 Jan 18;51(1):1701775. doi: 10.1183/13993003.01775-2017. Print 2018 Jan.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Comorbidity
  • Echocardiography
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage
  • Humans
  • Patient Selection*
  • Prognosis
  • Prospective Studies
  • Pulmonary Embolism / drug therapy*
  • Research Design*
  • Risk
  • Tenecteplase / therapeutic use
  • Thrombolytic Therapy / methods*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Tenecteplase